Advertisement
NSPR vs SI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NSPR is a Hold and SI is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
NSPR’s FA Score shows that 0 FA rating(s) are green whileSI’s FA Score has 1 green FA rating(s).
- NSPR’s FA Score: 0 green, 5 red.
- SI’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
NSPR’s TA Score shows that 4 TA indicator(s) are bullish while SI’s TA Score has 5 bullish TA indicator(s).
- NSPR’s TA Score: 4 bullish, 4 bearish.
- SI’s TA Score: 5 bullish, 4 bearish.
Price Growth
NSPR (@Medical/Nursing Services) experienced а -4.59% price change this week, while SI (@Medical/Nursing Services) price change was +31.02% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.36%. For the same industry, the average monthly price growth was -4.79%, and the average quarterly price growth was +5.70%.
Reported Earning Dates
NSPR is expected to report earnings on Mar 10, 2026.
Industries' Descriptions
@Medical/Nursing Services (+0.36% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| NSPR | SI | NSPR / SI | |
| Capitalization | 79.2M | 299M | 26% |
| EBITDA | -41.96M | N/A | - |
| Gain YTD | -31.939 | 1100.000 | -3% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 7.07M | N/A | - |
| Total Cash | 19.4M | N/A | - |
| Total Debt | 3.42M | N/A | - |
NSPR | SI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 56 | 83 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 45 Fair valued | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 99 | 25 | |
PRICE GROWTH RATING 1..100 | 91 | 34 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NSPR's Valuation (45) in the Medical Specialties industry is in the same range as SI (50) in the null industry. This means that NSPR’s stock grew similarly to SI’s over the last 12 months.
NSPR's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as SI (100) in the null industry. This means that NSPR’s stock grew similarly to SI’s over the last 12 months.
SI's SMR Rating (25) in the null industry is significantly better than the same rating for NSPR (99) in the Medical Specialties industry. This means that SI’s stock grew significantly faster than NSPR’s over the last 12 months.
SI's Price Growth Rating (34) in the null industry is somewhat better than the same rating for NSPR (91) in the Medical Specialties industry. This means that SI’s stock grew somewhat faster than NSPR’s over the last 12 months.
SI's P/E Growth Rating (100) in the null industry is in the same range as NSPR (100) in the Medical Specialties industry. This means that SI’s stock grew similarly to NSPR’s over the last 12 months.
| NSPR | SI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 82% |
| Stochastic ODDS (%) | 2 days ago 80% | 2 days ago 84% |
| Momentum ODDS (%) | 2 days ago 86% | 2 days ago 82% |
| MACD ODDS (%) | 3 days ago 89% | 2 days ago 70% |
| TrendWeek ODDS (%) | 2 days ago 86% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 86% | 2 days ago 90% |
| Advances ODDS (%) | 21 days ago 77% | 2 days ago 86% |
| Declines ODDS (%) | 3 days ago 88% | 4 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 85% | 2 days ago 75% |
| Aroon ODDS (%) | 2 days ago 88% | 2 days ago 90% |
Advertisement
NSPR and
Correlation & Price change
A.I.dvisor tells us that NSPR and SI have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NSPR and SI's prices will move in lockstep.
| Ticker / NAME | Correlation To NSPR | 1D Price Change % | ||
|---|---|---|---|---|
| NSPR | 100% | +9.82% | ||
| SI - NSPR | 29% Poorly correlated | +32.04% | ||
| CORBF - NSPR | 26% Poorly correlated | N/A | ||
| VAPO - NSPR | 25% Poorly correlated | N/A | ||
| EW - NSPR | 24% Poorly correlated | +0.49% | ||
| MLSS - NSPR | 23% Poorly correlated | -3.48% | ||
More | ||||
SI and
Correlation & Price change
A.I.dvisor indicates that over the last year, SI has been loosely correlated with OZK. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SI jumps, then OZK could also see price increases.